Posted On: 06/04/2014 3:30:31 PM
Post# of 171
$ADXS breakout gap $3.25
Website
10-Q 3/17/14
O/S shares 14,016,344.
Nasdaq
Data Published by Researchers at the National Cancer Institute Further Identifies How Advaxis's Lm-LLO Immunotherapy Eradicates Tumors
6/4/2014 8:00:00 AM - GlobeNewswire
Advaxis Mirrors Imclone Systems Prior To Acquisition
6/2/2014 5:17:00 PM - Seeking Alpha
Advaxis Presents New Long-Term Survival Data Greater Than 24-Months at ASCO Annual Meeting
5/31/2014 7:30:00 AM - GlobeNewswire
Advaxis Selects inVentiv Health Clinical to Conduct Clinical Trials of Immunotherapy Candidates
5/29/2014 7:30:00 AM - GlobeNewswire
Advaxis: ADXS-cHER2 Gets Orphan Drug Designation - Quick Facts
5/27/2014 7:39:00 AM - RTT News
recent trades
Stockwatch
% Buy Opinion (composite)
Website
10-Q 3/17/14
O/S shares 14,016,344.
Nasdaq
Data Published by Researchers at the National Cancer Institute Further Identifies How Advaxis's Lm-LLO Immunotherapy Eradicates Tumors
6/4/2014 8:00:00 AM - GlobeNewswire
Advaxis Mirrors Imclone Systems Prior To Acquisition
6/2/2014 5:17:00 PM - Seeking Alpha
Advaxis Presents New Long-Term Survival Data Greater Than 24-Months at ASCO Annual Meeting
5/31/2014 7:30:00 AM - GlobeNewswire
Advaxis Selects inVentiv Health Clinical to Conduct Clinical Trials of Immunotherapy Candidates
5/29/2014 7:30:00 AM - GlobeNewswire
Advaxis: ADXS-cHER2 Gets Orphan Drug Designation - Quick Facts
5/27/2014 7:39:00 AM - RTT News
recent trades
Stockwatch
% Buy Opinion (composite)
(0)
(0)
